Speaker illustration

Professor Marco Valgimigli

Cardiocentro Ticino Foundation, Lugano (Switzerland)

Member of:

EAPCI

Valgimigli’s research has influenced both European and USA clinical practice guidelines in multiple aspects. Impacting the coronary stent selection, regimens of various anti-thrombotic drugs & access site choice during coronary intervention. Initially starting as member/reviewer of multiple ESC guidelines task forces, he then acted as chair of the European update guidelines on DAPT. He acted as PI for multiple investigator initiated global randomized studies in interventional cardiology. Studies such as STRATEGY, ADVANCE, MULTISTRATEGY, 3T/2R, PRODIGY, Zotarolimus-eluting Endeavor sprint stent in Uncertain DES candidates (ZEUS), the Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of Angiox (MATRIX), GLOBAL LEADERS and HI-TECH.

Prolonged DAPT after acute coronary syndrome: individualise!

Event: Acute Cardiovascular Care 2019

Topic: Treatment

Session type: Case-Based Symposium

Thumbnail

The trial of the trial: Assessing GLOBAL LEADERS innovations, limitations and implications for clinical practice

Event: Acute Cardiovascular Care 2019

Topic: Antiplatelet Drugs

Session type: Special Session

Thumbnail

Acute complications in patients undergoing transcatheter aortic valve replacement

Event: Acute Cardiovascular Care 2019

Topic: Interventional Cardiology

Session type: Case-Based Symposium

Thumbnail

Meet the Guidelines task force - Focused update on dual antiplatelet therapy developed in collaboration with EACTS

Event: ESC CONGRESS 2017

Topic: PCI: long-term outcome

Session type: Special Session

Thumbnail

ESC Guidelines 2017 - Focused update on dual antiplatelet therapy developed in collaboration with EACTS

Event: ESC CONGRESS 2017

Topic: PCI / stents: devices and technique

Session type: New ESC Guidelines

Thumbnail

Hot topics in interventional cardiology 2016

Event: ESC CONGRESS 2016

Topic: Miscellaneous

Session type: Symposium

Thumbnail

This platform is supported by

logo Novo Nordisk